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Abstract 
Porcine epidemic diarrhea virus (PEDV) is an economically devastating enteric disease in the swine industry. The 
virus infects pigs of all ages, but it cause severe clinical disease in neonatal suckling pigs with up to 100% mortality. 
Currently, available vaccines are not completely effective and feedback methods utilizing PEDV infected material has 
variable success in preventing reinfection. Comprehensive information on the levels and duration of effector/memory 
IgA and IgG antibody secreting B cell response in the intestines and lymphoid organs of PEDV‑infected sows, and 
their association with specific antibody levels in clinical samples such as plasma, oral fluid, and feces is important. 
Therefore, our goal in this study was to quantify PEDV specific IgA and IgG B cell responses in sows at approximately 
1 and 6 months post‑infection in commercial swine herds, including parity one and higher sows. Our data indicated 
that evaluation of both PEDV specific IgA and IgG antibody levels in the plasma and oral fluid (but not feces) samples 
is beneficial in disease diagnosis. PEDV specific B cell response in the intestine and spleen of infected sows decline by 
6 months, and this associates with specific antibody levels in the plasma and oral fluid samples; but the virus neutrali‑
zation titers in plasma remains high beyond 6 months post‑infection. In conclusion, in sows infected with PEDV the 
presence of effector/memory B cell response and strong virus neutralization titers in plasma up to 6 months post‑
infection, suggests their potential to protect sows from reinfection and provide maternal immunity to neonates, but 
challenge studies are required to confirm such responses.
© 2015 Ouyang et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Porcine epidemic diarrhea (PED) clinically manifests as 
severe watery diarrhea with subsequent dehydration in all 
ages of swine, but highly severe in sucking pigs [1]. Other 
clinical signs of PED include vomiting and anorexia. PED 
is characterized by the mortality rate of 30–100% in neo-
nates, and high morbidity but low mortality in weaned 
pigs [2]. Economic losses due to elevated mortality and 
decreased production by PEDV are significant in the US 
swine herds. PED virus (PEDV) is the causative agent of 
PED. PEDV was detected on multiple US swine farms in 
April of 2013 [1, 3], and the virus has continued to spread 
through swine producing states at an alarming rate until 
the end of 2014. Over 45 779 PEDV tests have been con-
ducted in the US between May 2013 and March 2014, 
and reported 4757 cases (~10%) positive in 27 states [4].
PEDV is an enveloped virus having 28 kb genome 
and encode four structural proteins, spike (S), envelope 
(E), membrane (M), and nucleocapsid (N) [5, 6]. The 
S protein of PEDV is the principle surface glycoprotein 
involved in virus attachment and entry, and it contains 
virus-neutralizing B cell epitopes [7–9].
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PEDV continues to infect naive swine farms breaching 
strict biosecurity protocols for unknown reasons or has 
re-infected breeding farms after implementing feedback 
strategies. Piglets are expected to be protected from the 
clinical disease through colostral immunity received from 
immune dams [10]. However, protection from infection 
and shedding has been variable with occasional failure of 
feedback regimens. Control and prevention of PEDV is 
one of the major hurdles to the swine industry in the US.
Currently, available vaccines are not completely effec-
tive and feedback methods utilizing PEDV infected 
material has shown varied success in preventing rein-
fection. This could be attributed to non-availability of 
reliable diagnostic tools to monitor the protective herd 
immune status in sows. Moreover, information about 
levels and duration of PEDV herd immune status in sows 
is important to implicate appropriate control measures 
at verge of disease outbreaks. Therefore, it is critical to 
develop standardized isotype antibody targeted assays to 
determine the association of clinical samples data with 
PEDV specific B cell response at the intestines and lym-
phoid tissues of sows recovered from PED under field 
conditions. In this study we quantified both PEDV spe-
cific IgA and IgG antibody levels in the clinical samples 
(plasma, oral fluid, and feces) and associated that to the 
isotype specific B cell responses in the intestine and lym-
phoid tissues of PED infected sows in commercial breed-




Vero cells (ATCC® CCL-81) were cultured in Minimum 
Essential Media (Gibco, CA, USA) supplemented with 
10% heat inactivated fetal bovine serum (Atlanta Bio-
logicals, GA, USA), 2 mM l-glutamine (Gibco) and anti-
biotic/antimycotic solution (HyClone, UT) at 37  °C in a 
humidified atmosphere with 5% CO2. For preparation 
of virus stocks and in virus neutralizing (VN) assay, the 
MEM was supplemented with tocylsulfonyl phenylalanyl 
chloromethyl ketone (TPCK)-trypsin (1 μg/mL) (Sigma, 
MO, USA), 0.3% tryptose phosphate broth (Sigma), 
0.02% yeast extract (BD, MD) and antibiotic/antimycotic 
solution (HyClone, UT, USA).
Virus
PEDV strain KS 14-01 was isolated from PED infected 
field fecal samples at Kansas State University, and was 
propagated in Vero cells. Confluent cell monolayer was 
washed with sterile phosphate-buffered saline (PBS) 
twice before infecting with the virus, and after 1  h of 
adsorption at 37  °C additional infection medium was 
added without removing the inoculum. The virus induced 
cytopathogenic effect was reached to approximately 90% 
in 2–3 days. The virus culture supernatant was collected 
after freeze-thawing two times, and then clarified at high 
speed centrifugation (3000 × g for 30 min) and purified 
the viral antigen by ultracentrifugation through a 20% 
(wt/vol) sucrose cushion (100 000 × g for 2 h). Both the 
stock virus and viral antigen were stored at −80 °C until 
used. Viral protein concentration was measured by micro 
BCA protein assay kit (Thermo Scientific, IL, USA) and 
virus titer was determined by IFA as described previously 
[11–13].
Animals
Three swine breeding farms located in the Middle East-
ern part of the Unites States were chosen for this study, 
with the two farms having the history of piglet mortal-
ity and laboratory confirmation of PEDV infection by 
ELISA at approximately 1 and 6 months before necropsy, 
and the third farm had no history of PED infection. Six 
sows each from primiparous and multiparous group with 
a total of 36 sows with the history of PEDV infection or 
no infection were used in this study (Table  1). Animals 
were euthanized in a slaughter plant (Bob Evans slaugh-
terhouse, Xenia, Ohio) according to the standard pro-
cedures with necessary efforts to minimize suffering of 
animals. All the procedures on animals used in this study 
were approved by the Committee on the Ethics of Animal 
Experiments of The Ohio State University. On the day of 
necropsy, plasma, oral swab, and fecal samples were col-
lected for virus specific antibody isotype titration; and 
ileum, mesenteric lymph nodes (MLN), and spleen sam-
ples were collected in MEM containing antibiotics and 
antifungal for isolating mononuclear cells (MNCs).
Isolation of immune cells
MNCs from ileum, MLN, and spleen were isolated as 
previously described [14–17] with a few modifications. 
Briefly, ileum, spleen, and MLN tissues were cut into tiny 
pieces and only ileum tissues were treated with Type II 
collagenase after treating with EDTA and dithiothreitol. 
Cell suspensions were obtained after passing the digested 
tissues of ileum, spleen, and MLN through stainless steel 
Cellectors fitted with an 80  μm mesh screen (Cellector, 
FL, USA). The harvested MNCs were subjected to den-
sity gradient centrifugation with 43% and 70% Percoll, 
and the cells in the interface were collected and filtered 
through 40 μm cell strainer (BD Falcon, MA, USA) and 
re-suspended in enriched-RPMI (E-RPMI, RPMI con-
taining 10% FBS, 200 μm HEPES, 1 mM sodium pyruvate, 
25 μm 2-ME, 1x non-essential amino acid, and 1x antibi-
otic and antifungal). The viability of cells was confirmed 
by trypan blue dye exclusion method, and counted using 
a hemocytometer.
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In vitro stimulation of MNCs with PEDV antigen
MNCs isolated from ileum, MLN, and spleen were plated 
in 24-well cell culture plate (25 × 106 cells/well) in 2 mL 
E-RPMI in the presence of semi-purified PEDV viral anti-
gen (25 μg/mL), and cells treated with medium alone or 
lipopolysaccharide (25 μg/mL) were included as controls. 
Cells were cultured for 6 days at 39 °C with 5% CO2, and 
0.5 mL of E-RPMI was added to each well on every sec-
ond day. Supernatants were collected to measure PEDV 
specific IgA and IgG antibody by ELISA. Cells were har-
vested, washed using PBS, re-suspended in E-RPMI, 
counted and used for detecting the population of PEDV-
specific IgA and IgG antibody secreting cells (ASC) by 
enzyme linked immunospot (ELISPOT) assay, and for 
elucidating the frequency of IgA+ and IgG+ B cells by 
flow cytometry.
Antibody isotype ELISA
PEDV specific IgA and IgG antibody levels were deter-
mined as described previously [15, 16]. Briefly, pre-
titrated amounts of PEDV whole virus-derived antigen 
(5 μg/mL), recombinant PEDV S protein (5 μg/mL) or M 
protein (10  μg/mL) diluted in 50  mM carbonate buffer 
(pH 9.6) were coated overnight at 4  °C in the 96-well 
ELISA plates (Corning, MA, USA). Plates were blocked 
using 10% nonfat milk in PBS containing 0.05% Tween 
20. Plasma sample was diluted 1:200, 1:800, 1:3200, and 
1:12 800, and oral fluid and fecal samples were diluted 
1:8, 1:32, 1:128 and 1:512. The supernatants harvested 
from stimulated MNCs were diluted 1:2 and 50  μL of 
each of the samples was applied into duplicate wells and 
incubated for 1 h at room temperature (RT). Plates were 
washed and horseradish peroxidase-conjugated goat 
anti-pig IgA (Bethyl laboratories) or IgG antibody (KPL) 
(1:5000) was added to the plates and incubated for 1  h. 
The reaction was developed using TMB peroxidase sub-
strate and stopped using 1 M phosphoric acid and plates 
were read at OD450.
Virus titration and virus neutralizing (VN) antibody assays
PEDV titer in stocks and VN antibody titer in clinical 
samples were analyzed by IFA as described previously 
[11–13] with a few modifications. Briefly, confluent Vero 
cell monolayers in 96-well plates were washed once using 
PBS before seeding the samples. For virus titration, ten-
fold serially diluted virus stock was added to cells plate 
in quadruplicate; for VN titration, clinical samples were 
UV treated (254  nm for 45  min) and heat inactivated 
(56  °C for 30  min), and twofold serially diluted samples 
were incubated with equal volume of PEDV (50 TCID50 
per well) for 1.5  h at 37  °C, and the mixture was trans-
ferred into Vero cells grown in microtiter plates in dupli-
cate. Plates were incubated for 1 h at 37 °C and infection 
medium was added after the wells were washed once 
using PBS and incubated for 24  h at 37  °C. Plates were 
washed and fixed using acetone-Milli-Q water (8:2) mix-
ture for 10 min at RT, and dried completely before immu-
nostained. Cells were treated with anti-PEDV N protein 
specific monoclonal antibody (SD6-29) (Medgene lab, 
SD, USA) (1:1000) for 2  h at 37  °C, followed by treat-
ment with Alexa Fluor 488 conjugated goat anti-mouse 
IgG (H + L) (Invitrogen, CA, USA) secondary antibody 
(1:4000). The plate was examined under a fluorescent 
microscope after mounting with glycerol-PBS (6:4). The 
virus induced cytopathic effect was examined under 
a fluorescent microscope, and the titer was calculated 
using the Reed and Muench method. The viral titer was 
expressed in 50% tissue culture infective dose (TCID50) 
per mL. The VN titer was determined to be the reciprocal 
dilution of plasma/oral fluid/fecal samples that induced 
greater than 90% inhibition of viral infection as shown in 
virus control wells (Figure 2).
Enzyme linked immunospot (ELISPOT) assay 
for quantifying PEDV‑specific ASCs
ELISPOT assay was performed to analyze the population 
of PEDV specific IgA and IgG antibody secreting B cells 
as described previously [14–17] with few modifications. 
Briefly, two kinds of PEDV whole virus-derived anti-
gen coated plates were used in this study. (i) Vero cells 
infected and fixed cell culture plates: PEDV (100  μL of 
104 TCID50/mL) containing 1  μg/mL of TPCK-trypsin 
was inoculated to confluent Vero cell monolayers in 
96-well tissue culture plate. Cells were fixed with 80% 
acetone at 16  h post-infection and plates were stored 
Table 1 Grouping of sows at different stages of PEDV 
infection.
A total of 36 sows from three different swine breeding farms located in the 
Mid-Eastern part of the US, having a clear PEDV infection history (uninfected, 
1 month or 6 months post-infected) were selected, and six sows each from 
primiparous and multiparous groups were transported to a slaughter plant in 
Ohio. Clinical samples such as blood (plasma), oral fluid, and feces, and tissues 
of ileum, mesenteric lymph nodes, and spleen were collected on the day of 
necropsy.
Groups No. of  
sows
PEDV infection Status Abbreviation
1 6 Mock Primiparous Mock‑PP
2 6 Mock Multiparous Mock‑MP
3 6 1 month post‑
infection
Primiparous 1 m PI‑PP
4 6 1 month post‑
infection
Multiparous 1 m PI‑MP
5 6 6 months post‑
infection
Primiparous 6 m PI‑PP
6 6 6 months post‑
infection
Multiparous 6 m PI‑MP
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at −20 °C. At that stage about 80% of cells were infected 
as tested by IFA, and the cell monolayer was still intact. 
Mock-infected cells treated exactly the same way were 
used as control. (ii) PEDV whole virus-derived antigen 
immunocaptured plates: Semi-purified viral antigen 
(25 μg/mL) diluted in 50 mM carbonate buffer (pH 9.6) 
was coated overnight at 4  °C in nitrocellulose-based 
96-well microtiter plates (Millipore, MA, USA). Plates 
were washed with PBS and blocked with E-RPMI for 1 h 
at RT and stimulated MNCs of ileum, MLN, and spleen 
were plated at three tenfold dilutions in duplicate wells 
starting from 5  ×  105 cells/well. All plates were incu-
bated for 16 h at 39  °C with 5% CO2, and washed with 
PBS containing 0.05% Tween 20 (PBST). The antibody 
production was detected using horseradish peroxidase-
labeled affinity-purified goat anti-pig IgA (Bethyl labo-
ratories, Texas) or IgG (KPL, Maryland) diluted 1:2000 
in PBST and incubated for 2  h at 37  °C. The color was 
developed using 3-amino-9-ethylcarbazole substrate 
(Sigma-Aldrich, St. Louis, USA) and spots were counted 
using the AID ELISPOT Reader System (Autoimun 
Diagnostika GmbH Strassberg, Germany). Data were 
expressed as the mean numbers of ASCs per 5  ×  105 
MNCs.
Flow cytometric analyses
The frequencies of IgA+ and IgG+ B cells from 100 000 
acquired events of immunostained MNCs were deter-
mined by flow cytometry as described previously [18] 
with a few modifications. Briefly, MNCs were stimulated 
with PEDV whole virus-derived antigen as described 
above and immunostained with mouse anti-pig IgA mAb 
(Clone K60 1F1, AbD Serotec) followed by goat anti-
mouse IgG1 conjugated to APC/CY7 and rabbit anti-pig 
IgG conjugated to Texas Red. Subsequently, cells were 
fixed, permeabilized and then intracellular stained using 
FITC conjugated rat anti-mouse CD79β antibody (Clone 
AT107-2, AbD Serotec), which was shown to cross-react 
with pig B cells [18]. Cells were acquired using BD Aria II 
flow cytometer and analyzed using the FlowJo software.
Ethics statement
This study was carried out in strict accordance with 
the recommendations by Public Health Service Policy, 
United States Department of Agriculture Regulations, 
the National Research Council’s Guide for the Care and 
Use of Laboratory Animals, and the Federation of Animal 
Science Societies’ Guide for the Care and Use of Agri-
cultural Animals in Agricultural Research and Teaching 
and all the relevant institutional, state, and federal regu-
lations and policies regarding care and use of animals at 
the Ohio State.
Statistical analysis
All data were expressed as the mean ± standard error of 
mean (SEM) of six sows. Statistical analyses were per-
formed by one-way ANOVA followed by Tukey’s post 
hoc test (GraphPad InStat 5.0 prism software), and the P 
value of <0.05 was considered significant.
Results
Antibody response in PEDV infected sows
Details of sow groups used in this study are provided in 
Table 1. Clinically, sows were healthy before transporta-
tion to the slaughter plant at Xenia in Ohio and rested for 
a day before necropsy. PEDV specific IgA and IgG anti-
body responses were determined in plasma, oral fluid, 
and fecal samples using PEDV antigen, recombinant 
PEDV S and M protein coated plates. Our results indi-
cated PEDV specific IgA antibody response in the sam-
ples of plasma (Figure 1A) and oral fluid (Figure 1B) from 
both one and 6  months post-infected sows was signifi-
cantly higher than uninfected sows, and a similar trend 
was present in recombinant S (but not M) protein coated 
plates (Figures  1D  and E). Surprisingly, in fecal samples 
the specific IgA antibody against PEDV whole virus-
derived antigen (Figure 1C), S protein (Figure 1D), and M 
protein (Figure 1E) was absent.
Although PEDV specific IgG antibody levels in the 
plasma of infected sows was significantly higher than 
uninfected sows (Figures  1F, I  and J), the background 
optical density values of IgG from uninfected sows was 
higher compared to respective IgA levels (Figures  1A, 
D and E). In oral fluid samples of 6 months post PEDV-
infected primiparous sows, specific IgG antibody levels 
against whole viral antigen and recombinant S and M 
proteins were significantly higher than uninfected and 
other three infected sow groups (Figures  1G, I  and J). 
PEDV specific IgG antibody in fecal samples was absent 
in infected sows (Figures 1H, I and J). Our data suggests 
that for diagnostic antibody analysis of PEDV infection 
in sows, the plasma and oral fluid samples (but not fecal 
samples) are reliable and consistent.
Further, VN antibody titers against PEDV in infected 
sow samples were quantified by IFA. For this assay, 50 
TCID50 of PEDV in each well was used, which showed 
substantial amount of infected cells at 24 h post-infection 
(Figure  2). Our data revealed that in plasma of PEDV 
uninfected sows, the background VN titer was up to 16. 
But, in infected sows, the VN titer was very high in all 
four infected groups with a titer of 512 (Figure 3A), sug-
gesting that even after 6  months the VN titer in both 
primiparous and multiparous sows remained high in 
the plasma. The VN titers in oral fluid and fecal samples 
were <8 in all the infected sows (Figures 3B and C). 
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Flow cytometry analysis of PEDV specific IgA and IgG 
positive B cells in infected sows
Flow cytometry analysis allows simultaneous multi-par-
ametric analysis of the physical and chemical character-
istics of immune cells. MNCs isolated from ileum, MLN, 
and spleen were stimulated ex  vivo using PEDV whole 
virus-derived antigen for 6  days, and subsequently ana-
lyzed the frequency of effector/memory IgA+ and IgG+ 
B cells by flow cytometry. Ileum MNCs of PEDV infected 
sows stimulated with the virus antigen had significantly 
higher frequencies of both CD79+IgA+ and CD79+IgG+ 
B cells compared to uninfected sows (Figures 4B and H). 
In addition, the frequency of CD79+IgG+ B cells (but 
not CD79+IgA+ B cells) were also significantly higher in 
ileum MNCs unstimulated with medium control of three 
groups of PEDV infected sows (except 1 month multipa-
rous sows) compared to uninfected sows (Figures 4A and 
G). Specifically, antigen specific CD79+IgA+ and 
CD79+IgG+ B cell populations in the ileum of 1 month 
post PEDV-infected multiparous sows were significantly 
higher than 6  months post-infected animals with both 
primiparous and multiparous status (Figures  4B  and 
H). However, there was no significant changes in the 
frequency of both CD79+IgA+ and CD79+IgG+ B 
cells in the MLN MNCs of PEDV infected sows, either 
stimulated with viral antigen (Figures  4D  and J) or 
unstimulated medium control (Figures 4C and I).
In the spleen of all four post-PEDV-infected sow 
groups the frequency of CD79+IgA+ B cells was signifi-
cantly higher compared to their uninfected age-matched 
counterparts, either unstimulated or stimulated with 
PEDV whole virus-derived antigen (Figures  4E  and F). 
However, in both primiparous and multiparous sows at 
1 month post PEDV-infection, a significantly higher fre-
quency of CD79+IgG+ B cells was observed compared 
to both uninfected and 6  months post-infected coun-
terparts, either unstimulated or stimulated with PEDV 
whole virus-derived antigen (Figures  4K  and L). Fur-
ther, in the spleen of multiparous sows at 1 month post 
PEDV-infection, increased frequency of CD79+IgA+ B 
cells in unstimulated MNCs was significantly higher than 
that of primiparous and multiparous sows at 6  months 
post-infection (Figure  4E). In spleen of primiparous 
sows at 6  months post PEDV-infection, antigen specific 
CD79+IgA+ memory B cell population in antigen-stim-
ulated splenocytes was significantly less compared to 
that in multiparous sows at 1 and 6 month post-infection 
(Figure  4F). Overall, our data indicated that in PEDV-
infected multiparous sows, CD79+IgA+ B cell response 
is stronger than that of primiparous infected counterpart.
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Figure 1 Quantification of PEDV-specific IgA and IgG antibody titers in clinical samples of PEDV infected sows. Samples were collected 
from the uninfected and post PEDV‑infected sows as indicated in the Table 1. PEDV specific IgA (A–E) and IgG (F–J) antibody titers were quantified 
by ELISA, with plates coated either using PEDV whole virus‑derived antigen (A–C and F–H), S protein (D, I) or M protein (E, J); in plasma (A, D–F, 
I, J), oral fluid (B, D, E, G, I, J), and fecal (C–E and H–J) samples. Each bar represents mean OD450 value ± SEM from six sows. Lowercase alphabet 
indicates statistically significant difference between uninfected and PEDV‑infected corresponding parity sow groups, and asterisk indicates statisti‑
cal difference between the indicated PEDV‑infected sow groups (“a” or *P < 0.05, “b” or **P < 0.01 and “c” or ***P < 0.001).
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In the culture supernatants harvested at day six cul-
tures of ileum, MLN, and spleen MNCs from multiparous 
sows at 1 month post-infection, a significantly increased 
secretion of PEDV specific IgA antibodies specific to the 
virus was detected (Figure  5A). While in primiparous 
PEDV infected sows splenocytes stimulated with anti-
gen, a significantly increased IgA antibody secretion was 
detected (Figure  5B). While numerically increased (but 
not significant) trends in IgA antibody production was 











Virus control Sample dilution
Phase contrast IFA Phase contrast IFA
PEDV VNT positive titer of 512
A B
Figure 2 Representative pictures showing virus neutralizing antibody response in PEDV infected sows plasma samples. A Fifty TCID50 
of virus was used in the NA assay which showed appreciable quantity of infected cells by immunofluorescence (IFA) assay at 24 h post‑infection. 
B Each of representatives experimental plasma sample of PEDV uninfected and infected sows were twofold serially diluted from 1:8 to 1:1024 and 
mixed with 50 TCID50 of PEDV; and Vero cells treated with that mixture were subjected to IFA and examined under 200×magnification. VN titer was 
expressed as the reciprocal of the highest dilution ratio of test samples that caused greater than 90% reduction in virus induced fluorescence foci 
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Figure 3 Virus neutralizing antibody titers in PEDV infected sows. (A) Plasma, (B) Oral fluid and (C) fecal samples were analyzed for the VN 
titers against PEDV by immunofluorescence assay. The VN titer was determined as the reciprocal dilution of the test sample that induced greater 
than 90% inhibition of viral infection. Each bar represents mean VN titers ± SEM from six sows. Lower case alphabet indicates a statistically signifi‑
cant difference (“a” P < 0.05 and “b” P < 0.01) between mock‑uninfected and PEDV‑infected corresponding primiparous and multiparous sow groups.
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three tissues against the S protein, and against M protein 
the antibody levels were very low (Figures 5C and D). In 
the splenocytes from primiparous sows at 1 month post 
PEDV-infection, a significantly higher secretion of virus 
specific IgG antibodies was detected (Figure 5F).
Quantification of PEDV secreting IgA and IgG ASC 
in infected sows
ELISPOT assay allows visualization of the secretory 
product(s) of individual activated cells, and thus provides 
both qualitative and quantitative information on T and B 
cell responses. Population of PEDV specific IgA and IgG 
secreting cells (ASCs) present in every 0.5 million MNCs 
of ileum, MLN and spleen were enumerated by ELISPOT 
assay (Figure  6). To perform this assay, we used both 
PEDV whole virus-derived antigen containing fixed Vero 
cells plate and semi-purified PEDV antigen immuno-
captured plate. Both the methods detected similar trend 
in the frequencies of both IgA and IgG ASCs in PEDV 
infected sow groups, but in fixed Vero cell antigen coated 
plates, a fivefold to tenfold higher numbers of ASCs were 
detected compared to the other, therefore fixed cell anti-
gen plate data is shown here (Figure 6). As expected we 
did not detect PEDV specific IgA and IgG ASCs in both 
uninfected primiparous and multiparous sows (Figure 6). 
Overall, the population of PEDV specific IgA ASCs was 
greater than IgG ASCs in all three tissue derived MNCs 
(Figure 6).
In post 1  month PEDV-infected multiparous sows 
ileum MNCs, cultured for 6  days without any further 
antigenic stimulation, the number of virus-specific IgA 
ASCs (~200) were significantly greater compared to con-
trol uninfected and 6  months post PEDV-infected (10 
ASCs) sows (Figure 6A); and a similar trend was present 
in stimulated ileum MNCs (Figure  6B). In contrast, the 
number of virus-specific IgG ASCs were too low (<5) in 
the ileum MNCs (Figures 6G and H). In MLN MNCs, the 
number of PEDV-specific IgA ASCs in multiparous sows 
at 1 and 6 months post PEDV-infection were significantly 
higher compared to uninfected control sows (Figures 6C 
and  D). In unstimulated MNCs of spleen, frequency 
of PEDV-specific IgA ASCs (~400) in all four PEDV-
infected sow groups were significantly higher than that 
from uninfected control sows (Figure  6E); and only in 
PEDV-infected multiparous sows, a significant increase 
in IgA ASCs in viral antigen-stimulated MNCs was 
observed compared to uninfected animals (Figure  6F). 
However, significantly greater numbers of PEDV-specific 
IgG ASCs (~300) were present only in the PEDV whole 
virus-derived antigen stimulated MNCs from multipa-
rous sows at 1  month post PEDV-infection in compari-
son to that of uninfected control sows (Figure 6L).
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Figure 4 Flow cytometry analyses to determine the frequency of IgA+ and IgG+ B cells in mucosal tissues of PEDV infected sows. 
Mononuclear cells were isolated from ileum (A, B, G, H), mesenteric lymph nodes (C, D, I, J), and spleen (E, F, K, L), and stimulated ex vivo with 
PEDV whole virus‑derived antigen (B, D, F, H, J, L) or medium control (A, C, E, G, I, K) for 6 days. The frequency of B cells positive for IgA (A–F) and 
IgG (G–L) antibodies were determined by flow cytometry. Each bar represents the mean of percent of lymphocytes positive for IgA or IgG positive 
B cells ± SEM from six sows. Lowercase alphabet indicates statistically significant difference between uninfected and PEDV‑infected corresponding 
parity sow groups, and asterisk indicates statistical difference between the indicated PEDV‑infected sow groups (“a” or *P < 0.05, “b” or **P < 0.01 and 
“c” or ***P < 0.001).
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Discussion
We evaluated PEDV specific B cell response in 24 
infected sows at approximate 1 and 6 months post-infec-
tion, comprising of both primiparous and multiparous 
sow groups and included 12 age-matched control unin-
fected sows. In an earlier study, PEDV whole virus anti-
gen based ELISA was developed using the virus grown 
in Vero cells, and the viral antigen used in the assay was 
extracted using 0.2% Triton X-100 to analyze antibod-
ies in 1024 field samples at the herd level [19]. Though 
we followed a similar method of growing the virus, but 
the ELISA antigen was extracted from freeze-thawed 
viral culture fluid subjected to 20% sucrose cushion 
ultracentrifugation, probably the cell debris still present 
in our antigen preparation would have contributed to 
the observed high background activity in IgG ELISA in 
plasma, which needs further investigation.
PEDV S protein is a class I viral fusion protein [20], 
and is cleaved by host-derived proteases when virus 
enters the susceptible cell [21]. The S protein contains 
B cell epitopes for induction of neutralizing antibodies 
[22]. The S protein-based ELISA was found to be sen-
sitive to evaluate antibody response against PEDV in 
plasma and colostrum samples [23–26]. In our study, 
in addition to whole virus antigen, both recombinant 
PEDV S and M protein based IgA and IgG ELISA was 
used to estimate the levels of antibody in plasma, oral 
fluid, and fecal samples of sows; and detected high lev-
els of specific IgA response in infected sows’ plasma 
followed by in oral fluid, but not in fecal samples. This 
suggests that PEDV specific antibodies in the fecal 
samples of infected sows disappear early (approxi-
mately 1–2 months) post-infection; in spite of the pres-
ence PEDV specific IgA and IgG ASCs in intestines 
and lymphoid organs at 6  months post-infection. We 
also noticed that PEDV specific IgA response in plasma 
(but not in oral fluid) remained high until 6  months. 
Furthermore, though we found comparable reactiv-
ity of PEDV whole virus derived antigen and S protein 
for detection of specific IgA antibodies, the antibody 
levels were twofold less in the S protein based ELISA 
(ODs at 1:200 dilution). Overall, our data suggested 
that for diagnosis purpose it is ideal to use both whole 
virus and S protein based IgA and IgG ELISA in herd 
oral fluid as well as in statistically acceptable number of 
plasma samples.
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Figure 5 Analysis of PEDV specific IgA and IgG antibodies secreted by stimulated MNCs of ileum, mesenteric lymph nodes, and 
spleen. Culture supernatants were harvested on day six from MNCs stimulated ex vivo with PEDV whole virus‑derived antigen (B–D, F–H) or 
control unstimulated (A, E). PEDV specific IgA (A–D) and IgG (E–H) levels were determined by ELISA, with plates coated either with PEDV whole 
virus‑derived antigen (A, B and E, F), S protein (C, G) or M protein (D, H). Each bar represents mean OD450 value ± SEM from six sows. Lowercase 
alphabet indicates statistically significant difference between uninfected and PEDV‑infected corresponding parity sow groups, and asterisk indicates 
statistical difference between the indicated PEDV‑infected sow groups (“a” or *P < 0.05, “b” or **P < 0.01 and “c” or ***P < 0.001).
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Consistent with the results of others [14, 27, 28], we 
did not detect PEDV specific response in ileum MNCs 
of uninfected sows, confirming their PEDV negative 
status and suggesting the need of in vivo priming of the 
immune system by the live virus to observe the response. 
But like earlier results in PEDV infected experimental 
piglets [16], we observed significantly increased popula-
tion of PEDV specific ASCs and IgA and IgG positive B 
cells in the ileum and spleen of sows in in vitro cultured 
MNCs for 6 days in the absence of viral antigen restimu-
lation, indicating the presence of virus specific effector B 
cells for up to 6 months in PEDV infected sows. In one of 
our previous study in pigs vaccinated/infected with por-
cine reproductive and respiratory syndrome virus a simi-
lar recall lymphocyte response in lung MNCs and PBMC 
cultured in vitro in the absence of the virus antigen was 
observed [12, 29].
Interestingly, we detected substantially higher fre-
quency of PEDV specific ASCs compared to the results of 
an earlier study [16], this could be attributed to difference 
in the age of pigs and the virus strain used in the study. At 
this stage due to lack of pig specific B cell memory marker 
reagent we could not analyze the frequency of memory B 
cell pool by flow cytometry in PEDV infected sows.
When PEDV specific IgA and IgG responses in clini-
cal samples were compared with the antibody secreting 
B cell population in the ileum, MLN, and spleen of sows 
analyzed by both flow cytometry and ELISPOT assays; 
surprisingly, multiparous sows had increased humoral 
response both in terms of antibody and B cell response 
compared to primiparous animals, and that response 
was high in 1 month post-infected sows and declined by 
6 months. But the VN titers in plasma remained high in 
all the PEDV-infected sows, suggesting that infected sows 
could be resistant to reinfection beyond 6 months. How-
ever, the level of protection varies depending on extent 
of viral antigenic diversity, health status of sows, and 
secondary microbial infections. Due to lack of virus iso-
lation from PEDV-infected sows, the genetic variability 
between the virus that infected sows and the virus used 
for ex  vivo stimulation could not be analyzed, and thus 
we could not determine the levels of cross-protection to 
PEDV in sows.
In an earlier experimental study, 11  days old conven-
tional pigs were infected with PEDV, and specific IgA and 
IgG ASCs in the intestines were detected at higher levels 
than in systemic sites (spleen and PBMC) [16]. However, 
in sows naturally infected with PEDV, we observed higher 
levels of IgA and IgG ASCs in spleen than in intestines, 
suggesting that systemic response is equally important 
and it persists for longer time in infected sows com-
pared to piglets. Suckling and gnotobiotic pigs infected 
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PEDV specific IgG secreting cells by ELISPOT
Figure 6 ELISPOT analyses to quantify PEDV specific IgA and IgG antibody secreting cell population in ileum, mesenteric lymph 
nodes, and spleen of PEDV infected sows. MNCs isolated from ileum (A, B, G, H), MLN (C, D, I, J), and spleen (E, F, K, L) were stimulated ex vivo 
with PEDV whole virus‑derived antigen (B, D, F, H, J, L) or medium control (A, C, E, G, I, K) for 6 days. PEDV specific IgA (A–F) and IgG (G–L) 
antibody secreting cells (ASCs) were detected by ELISPOT. Each bar represents mean number of PEDV‑specific ASCs per 5 × 105 MNCs from six 
sows. Lowercase alphabet indicates statistically significant difference between uninfected and PEDV‑infected corresponding parity sow groups, and 
asterisk indicates statistical difference between the indicated PEDV‑infected sow groups (“a” or *P < 0.05, “b” or **P < 0.01 and “c” or ***P < 0.001).
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with TGEV and rotavirus, respectively, had higher num-
bers of specific IgG ASCs compared to IgA ASCs in the 
intestines [14, 16, 27, 30]. But in our study, in both one 
and 6  months post PEDV-infected primiparous and 
multiparous sows, the frequency of specific IgA ASCs 
were greater than IgG ASCs in the intestines, MLN, and 
spleen. This suggests the enhanced susceptibility of neo-
natal pigs to PEDV is responsible for induction of greater 
levels of IgG ASCs in the intestinal tissues in compari-
son to that of sows which experience low to mild level of 
PEDV-infection.
Since PEDV infection is localized to intestinal mucosa, 
stimulation of systemic immune response especially in 
piglets is at very low levels [31, 32]. However, our study 
in sows suggested that systemic response in spleen is pre-
dominant over the response in intestines; the differences 
might be due to time frame of sampling and the age of 
the animals. Immunologically, the possible reason could 
be the migration of activated PEDV antigen-bearing den-
dritic cells to spleen, resulting in activation of naïve B and 
T cells. Alternatively, the memory lymphocytes from the 
mucosa- associated lymphoid tissues could migrate to 
spleen and bone marrow [33]. In summary, PEDV spe-
cific IgA and IgG B cells in infected sows were detectable 
at higher levels in ileum and spleen compared to that in 
MLN using both ELISPOT (total B cell response) and 
flow cytometry (detection of frequency of specific IgA 
and IgG B cell response) assays, with the later assay dem-
onstrating a more robust result compared to the former 
in detecting antigen and isotype specific B cells. However, 
detection of antibody isotype specific B cell response 
with a memory phenotype marker in mucosal tissues will 
be highly beneficial to determine PEDV vaccine or infec-
tion induced memory in pigs.
In conclusion, our results suggests that detection of 
PEDV specific IgA in plasma and oral fluid samples has 
a potential diagnostic implication, and estimation of VN 
titers in plasma could serve to determine the protective 
immune status. Although PEDV specific B cell response 
decline by 6 months in both ileum and spleen of naturally 
infected sows, the presence of high levels of VN titers 
suggest that such sows may protect their offspring from 
PEDV infection by genetically closely related virus by up 
to 6 months.
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